Company news

Fennec Pharmaceuticals Inc. news in 2021

Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2021, newest first.

View company

Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors

November 29, 2021

Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors

November 28, 2021

Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update

November 9, 2021

Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update

August 9, 2021

Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility

June 23, 2021

Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK™

June 21, 2021

Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK™

May 27, 2021

Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021

Fennec Announces Fiscal Year 2020 Financial Results and Provides Business Update

March 29, 2021

Decks in 2021